Stoke Therapeutics, Inc. (STOK) stock
STOKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30179% above fair value
$26.68+0.48 (+1.83%)
Close on Nov 13, 2026Market cap $1.72BP/E –Yield –
Stoke Therapeutics statistics
81 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Jan 11, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 4.98
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 51.79
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 5.29%
- 10.8%
- Shares Change (QoQ)
- 0.26%
- 0.50%
- Float
- 38M
- 49M
- Shares Held by Insiders
- 41.6%
- 11.7%
- Shares Held by Institutions
- 119.9%
- 56.4%
Short sellingIndustry
- Short Interest
- 11M
- –
- Short Interest Change
- 4.54%
- -0.80%
- Short % of Float
- 28.5%
- 9.01%
- Short % of Shares Outstanding
- 16.6%
- 6.30%
- Days to Cover
- 6.75
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $40.22
- –
- 52-Week Low
- $22.05
- –
- 20-Day Moving Average
- $26.38
- –
- 50-Day Moving Average
- $26.45
- –
- 200-Day Moving Average
- $30.79
- –
- Average True Range (14)
- $1.28
- –
- Price Change (1 Week)
- 0.53%
- -1.15%
- Price Change (1 Month)
- 8.41%
- -4.87%
- Price Change (3 Months)
- -17.0%
- -21.0%
- Price Change (6 Months)
- -11.3%
- -20.6%
- Price Change (YTD)
- -15.9%
- -23.6%
- Price Change (1 Year)
- 6.17%
- -22.4%
- Price Change (3 Years)
- 466.5%
- -29.5%
- Price Change (5 Years)
- -6.12%
- -77.9%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 962,918
- –
- Relative Volume
- 0.44
- 0.70
- Relative Strength Index (14)
- 51.3
- 43.4
- Volatility (1 Year)
- 53.2%
- 80.1%
- Beta (5 Years)
- 1.62
- 1.07
MarginsIndustry
- EBITDA Margin
- -809.7%
- -27.7%
- FCF Margin
- -654.9%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -61.1%
- -49.9%
- Return on Assets (ROA)
- -53.4%
- -40.6%
- Return on Invested Capital (ROIC)
- -252.2%
- -32.9%
- Return on Capital Employed (ROCE)
- -63.5%
- -37.9%
Financial positionIndustry
- Current Ratio
- 7.69
- 3.30
- Quick Ratio
- 7.15
- 2.39
- Interest Coverage
- -4856.02
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- -86.2%
- 6.82%
- Net Income Growth (YoY)
- -496.1%
- -14.4%
- EPS Growth (YoY)
- -501.2%
- -12.3%
- FCF Growth (YoY)
- -395.5%
- 6.85%
- Revenue Growth (3Y CAGR)
- 145.9%
- 2.25%
EfficiencyIndustry
- Asset Turnover
- 0.07
- 0.40
- Revenue Per Employee
- $162.28K
- $429.29K
- Profits Per Employee
- -$1.22M
- -$689.41K
- Employee Count
- 170
- 74
- WACC
- 13.2%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $292.82M
- $17.76M
- Net Cash Per Share
- $4.54
- $0.80
- Equity (Book Value)
- $345.55M
- $53.89M
- Book Value Per Share
- $5.36
- $1.50
- Tangible Book Value
- $345.55M
- $27.13M
- Working Capital
- $280.61M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$2.69M
- -$1.00M
- FCF Per Share
- -$2.80
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -12.1%
- -21.8%
- FCF Yield
- -10.5%
- -9.44%
Taxes and interestIndustry
- Interest Expense
- $46.00K
- $2.90M
- Income Tax
- -$1.28M
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- 18.22
- 0.23
- Piotroski F-Score
- 5
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | STOK | S&P 500 | Difference | STOK per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +18.6% | -3.0% | +21.6 pts | ||
| 3 months | -14.8% | -2.8% | −12.0 pts | ||
| Year to date | -15.9% | +11.5% | −27.4 pts | ||
| 1 year | +2.3% | +13.5% | −11.1 pts | ||
| 3 years | +524.8% | +77.7% | +447.1 pts | +84.2% | +21.1% |
| 5 years | -6.1% | +72.6% | −78.7 pts | -1.3% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
11M STOK shares were sold short on Oct 30, 2026, up 4.5% from the previous report, or 28.45% of the shares available to trade. At recent volumes it would take 6.8 days to buy them back. Over the last 20 sessions, 63.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 10,722,415 | +4.5% | 1,588,157 | 6.8 |
| Oct 15, 2026 | 10,256,830 | -10.9% | 831,757 | 12.3 |
| Sep 30, 2026 | 11,505,410 | +3.2% | 1,131,259 | 10.2 |
| Sep 15, 2026 | 11,150,236 | -0.5% | 643,984 | 17.3 |
| Aug 31, 2026 | 11,203,427 | -13.7% | 944,065 | 11.9 |
| Aug 14, 2026 | 12,978,102 | -17.9% | 1,021,869 | 12.7 |
| Jul 31, 2026 | 15,809,687 | +0.7% | 571,435 | 27.7 |
| Jul 15, 2026 | 15,692,610 | +12.8% | 757,040 | 20.7 |
| Jun 30, 2026 | 13,908,522 | +18.7% | 1,389,992 | 10.0 |
| Jun 15, 2026 | 11,721,496 | +4.4% | 523,966 | 22.4 |
| May 29, 2026 | 11,227,175 | -13.1% | 586,910 | 19.1 |
| May 15, 2026 | 12,917,969 | -0.8% | 521,888 | 24.8 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?